Is AGL p.Arg910Gln (c.2729G>A) pathogenic?

AGL p.Arg910Gln (c.2729G>A) is classified Uncertain significance in AGL (ClinVar, Multiple submitters, 3 submitters; last evaluated 2024-06-03). AlphaMissense: likely benign (0.2601); Ultra-rare (popmax 0.0163%, nfe); Associated with glycogen storage disease III.

What condition is associated with AGL p.Arg910Gln (c.2729G>A)?

AGL p.Arg910Gln (c.2729G>A) is associated with glycogen storage disease III (ClinVar).

How common is AGL p.Arg910Gln (c.2729G>A) in the general population?

AGL p.Arg910Gln (c.2729G>A) is ultra-rare (popmax 0.0163%, nfe) (gnomAD).

What do computational predictors say about AGL p.Arg910Gln (c.2729G>A)?

AlphaMissense predicts likely benign (score 0.2601) — an in-silico prediction, not a clinical call.

AGL p.Arg910Gln

Q: How is Glycogen storage disease due to glycogen debranching enzyme deficiency inherited?

Typically Autosomal recessive (Orphanet). A genetic counselor can assess individual risk for a family.

c.2729G>A · rs369044372 · VCV966286

Uncertain significance Multiple submitters

Classification

Uncertain significance

ClinVar

Review

Multiple submitters ★★☆☆

ClinVar · 3 submitters

AlphaMissense

likely benign

0.2601 · ACMG-weighted

gnomAD v4.1

Rare

ultra-rare (popmax 0.0163%, nfe)

Missense predictors

0/2 damaging

AlphaMissense, SaProt · REVEL no call

Conditions

glycogen storage disease III

Computational evidence

Protein change
AlphaMissense	0.2601	likely benign
REVEL	0.347	indeterminate
SaProt	LLR -9.26	tolerated
⇒ AlphaMissense and SaProt both call this tolerated; REVEL makes no call.
Splicing
SpliceAI	—	not assessed · no allele here is in the release
Constraint at this position
Conservation	phyloP 12	GERP 1.7, phastCons 1
Regional constraint	o/e 0.99	unconstrained · MANE · 71 kb · p 0.78 · regional, not allelic
Overall
CADD	27.4	PHRED · no single calibrated threshold — expert panels disagree

ClinVar classifies this uncertain; the computational predictors unanimously lean tolerated — a triage signal, not a reclassification

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes

Grpmax group 0.0163% European (non-Finnish) · 192/1,179,600 alleles

Filtering AF 0.0144% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.0136%

Overall 0.0128% 207/1,613,276 alleles · ultra-rare

Ancestry group	Frequency	1 in
European (non-Finnish)grpmax	0.0163%	6,144
Remaining individualsnot grpmax-eligible	0.0128%	7,805
Admixed American	0.00667%	14,982
African / African-American	0.00267%	37,431
Finnishnot grpmax-eligible	0.00156%	63,960

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene: AGL
Protein: p.Arg910Gln
Coding: c.2729G>A
MANE Select: NM_000642
dbSNP: rs369044372
Type: single nucleotide variant
Location: chr1:99888025 (GRCh38)
Gene constraint: LOEUF 0.72 · pLI <0.01 (gnomAD)
Structure: AlphaFold pLDDT 92.88 · 1 PDB
Residue 910: the 'amylo-1,6-glucosidase' region

Full AGL gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

glycogen storage disease III — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

For Glycogen storage disease due to glycogen debranching enzyme deficiency (Orphanet):

Inheritance: Autosomal recessive
Onset: Childhood, Infancy
Prevalence: 1-9 / 100 000 (United States)

Similar variants

AGL p.Arg910Ter Pathogenic ★★ same residue
AGL p.Arg910Leu Uncertain significance ★ ⚠ same residue
AGL p.Arg910= Uncertain significance same residue
AGL c.1283+2T>C Likely pathogenic ★★ same condition
AGL c.1284-1G>A Likely pathogenic ★★ same condition
AGL c.1284-2A>G Likely pathogenic ★★ same condition
AGL c.1423+1G>A Pathogenic ★★ same condition
AGL c.1423+1G>C Pathogenic ★★ same condition

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/agl-p-arg910gln (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown